학술논문
KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study
Document Type
Article
Author
Shah, B.D.; Ghobadi, A.; Oluwole, O.O.; Logan, A.C.; Boissel, N.; Cassaday, R.D.; Leguay, T.; Bishop, M.R.; Topp, M.S.; Tzachanis, D.; O'Dwyer, K.M.; Arellano, M.L.; Lin, Y.; Baer, M.R.; Schiller, G.J.; Park, J.H.; Subklewe, M.; Abedi, M.; Minnema, M.C.; Wierda, W.G.; DeAngelo, D.J.; Stiff, P.; Jeyakumar, D.; Feng, C.; Dong, J.; Shen, T.; Milletti, F.; Rossi, J.M.; Vezan, R.; Masouleh, B.K.; Houot, R.
Source
In: The Lancet . (The Lancet, 7 August 2021, 398(10299):491-502)
Subject
Language
English
ISSN
1474547X
01406736
01406736